Search results
Results from the WOW.Com Content Network
According to pediatric endocrinology expert Brad Miller, pharmaceutical companies that make puberty blocker drugs for children with gender dysphoria have refused to submit them for FDA approval because doing so would cost too much money and "because (transgender treatment) was a political hot potato."
A study into the effects of the benzodiazepine receptor antagonist, flumazenil, on benzodiazepine withdrawal symptoms persisting after withdrawal was carried out by Lader and Morton. Study subjects had been benzodiazepine-free for between one month and five years, but all reported persisting withdrawal effects to varying degrees.
Zaleplon is a high-selectivity, [26] high-affinity ligand of positive modulatory benzodiazepine sites on GABA A receptors. Zaleplon binds preferentially at benzodiazepine sites on α1-containing GABA A receptors (previously known as BZ1/Ω1 receptors), which largely mediate the sedative effects of benzodiazepines. [ 27 ]
Diazepam, sold under the brand name Valium among others, is a medicine of the benzodiazepine family that acts as an anxiolytic. [15] It is used to treat a range of conditions, including anxiety, seizures, alcohol withdrawal syndrome, muscle spasms, insomnia, and restless legs syndrome. [15]
(The Center Square) – The U.S. Supreme Court on Wednesday began weighing its role in determining whether a Tennessee law banning medication to treat gender dysphoria for minors violates the ...
The committee found that the regular use of benzodiazepines causes the development of dependence characterized by tolerance to the therapeutic effects of benzodiazepines and the development of the benzodiazepine withdrawal syndrome including symptoms such as anxiety, apprehension, tremors, insomnia, nausea, and vomiting upon cessation of ...
An Oregon dad who pleaded guilty to serving drug-laced smoothies at his 12-year-old daughter's sleepover says he just wanted the girls to go to sleep, according to his his lawyer.
Feb. 15—ROCHESTER — Mayo Clinic explains its decision to not treat out-of network Medicare Advantage patients is solely about "capacity" versus lower reimbursement rates. "Mayo simply does not ...